A Study of the Safety, Tolerability, and Efficacy of MK-8353 in Participants With Advanced Solid Tumors (MK-8353-001)
Clinical trial NCT01358331 · TERMINATED
Trial details
- NCT number
- NCT01358331
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-04
- Primary completion
- 2014-05-20
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.